Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Precision Oncology Program for Cancer of the Prostate Authorization Act of 2026. H.R. 8553. 119th Cong., 2nd sess., Introduced in House April 28, 2026. https://www.govinfo.gov/app/details/BILLS-119hr8553ih.
Congress, House of Representatives (2026, April 28). Precision Oncology Program for Cancer of the Prostate Authorization Act of 2026 (H.R. 8553 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr8553ih.
United States, Congress, House of Representatives. Precision Oncology Program for Cancer of the Prostate Authorization Act of 2026. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr8553ih. 119th Congress, H.R. 8553, Introduced in House 28 Apr. 2026.
H.R.8553 - 119th Congress (2025-2026): Precision Oncology Program for Cancer of the Prostate Authorization Act of 2026, H.R.8553, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr8553ih.